32
Participants
Start Date
June 30, 2016
Primary Completion Date
May 31, 2018
Study Completion Date
May 31, 2018
nasal high flow therapy
The nasal high flow therapy has enabled high flow oxygen to be derived through nasal cannula. This mode not only allows constant FiO2 during peak inspiratory flow but also confers benefits including a low level of continuous positive airway pressure with increased end-expiratory lung volume and reduced work of breathing, partly through intrinsic positive end-expiration pressure compensation and dead space washout. The inspired gases are warmed and humidified, improving comfort and possibly reducing airway inflammation, leading to improved drainage of respiratory secretions.
National Hospital Organization Minami Kyoto Hospital, Jōyō
National Hospital Organization Minami Kyoto Hospital
OTHER